In a report released on February 14, Christophe dombu from Kepler Capital maintained a Buy rating on Hyloris Pharmaceuticals SA (52U – Research Report), with a price target of €16.00.

The mouse on the right with four times the normal muscle mass is placed with a normal mouse. Handout via REUTERS About a dozen drugmakers are developing new weight-loss treatments aimed at ...

The 21st century pharmaceutical and biotech sector has come a long way from its roots in 19th century pharmacy. pharmaphorum looks at its evolution over the centuries. The roots of the ...

As one of the world’s biggest contributors to climate change, pharma is morally obliged to adapt its processes and operations – and doing so will open up new opportunities for growth.

Rocket Pharmaceuticals (RCKT) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising ...

U.S.-based hedge fund Viking Global built a $526 million-worth new position in planemaker Boeing in the fourth quarter, with 2.9 million shares, and roughly doubled bets on JPMorgan Chase, a ...

After hours: February 20 at 6:45:21 PM EST Loading Chart for VRNA ...

Companies that have grown profits and net profit margins over the past 12 months ...

Natco Pharma Ltd., incorporated in the year 1981, is a Mid Cap company (having a market cap of Rs 14,561.63 Crore) operating in Pharmaceuticals sector. Natco Pharma Ltd. key Products/Revenue Segments ...

Rights Aug 02, 2023 Aug 02, 2023 Feb 08, 2023 Rights ratio: 5 share for every 46 held at a price of Rs 81.0 ...

IPC Indice de Precios Y Cotizaciones 54,476.74 185.10 0.34% ...

Biopharmaceutical company developing drugs for neurological disorders.